,Characteristic/risk factor,Exposure,Outcomes,Statistic,Value,Unit,Variability statistic,Variability value,Interval type,Lower limit,High limit,P value
0,Gestational age in weeks, , Dexamethasone, median,25.1, weeks, IQR, 24.3–26.6, , , , 
1,Gestational age in weeks, , Late hydrocortisone, median,25.4, weeks, IQR, 24.3–27.6, , , , 
2,Gestational age in weeks, , Prednisolone, median,25.4, weeks, IQR, 24.5–26.7, , , , 
3,Gestational age in weeks, , Methyl-prednisolone, median,24.9, weeks, IQR, 24.1–28.0, , , , 
4,Gestational age in weeks, , Inhaled budesonide, median,25.7, weeks, IQR, 24.6–27.3, , , , 
5,Gestational age in weeks, , Early hydrocortisone, median,25, weeks, IQR, 24.0–27.0, , , , 
6,Antenatal corticosteroids, None, Dexamethasone, frequency,166, , , , , , , 
7,Antenatal corticosteroids, None, Late hydrocortisone, frequency,43, , , , , , , 
8,Antenatal corticosteroids, None, Prednisolone, frequency,26, , , , , , , 
9,Antenatal corticosteroids, None, Methyl-prednisolone, frequency,2, , , , , , , 
10,Antenatal corticosteroids, None, Inhaled budesonide, frequency,25, , , , , , , 
11,Antenatal corticosteroids, None, Early hydrocortisone, frequency,3, , , , , , , 
12,Antenatal corticosteroids, Complete, Dexamethasone, frequency,2306, , , , , , , 
13,Antenatal corticosteroids, Complete, Late hydrocortisone, frequency,677, , , , , , , 
14,Antenatal corticosteroids, Complete, Prednisolone, frequency,344, , , , , , , 
15,Antenatal corticosteroids, Complete, Methyl-prednisolone, frequency,24, , , , , , , 
16,Antenatal corticosteroids, Complete, Inhaled budesonide, frequency,699, , , , , , , 
17,Antenatal corticosteroids, Complete, Early hydrocortisone, frequency,124, , , , , , , 
18,Antenatal corticosteroids, Incomplete, Dexamethasone, frequency,574, , , , , , , 
19,Antenatal corticosteroids, Incomplete, Late hydrocortisone, frequency,165, , , , , , , 
20,Antenatal corticosteroids, Incomplete, Prednisolone, frequency,98, , , , , , , 
21,Antenatal corticosteroids, Incomplete, Methyl-prednisolone, frequency,5, , , , , , , 
22,Antenatal corticosteroids, Incomplete, Inhaled budesonide, frequency,151, , , , , , , 
23,Antenatal corticosteroids, Incomplete, Early hydrocortisone, frequency,37, , , , , , , 
24,Antenatal corticosteroids, Missing, Dexamethasone, frequency,2405, , , , , , , 
25,Antenatal corticosteroids, Missing, Late hydrocortisone, frequency,667, , , , , , , 
26,Antenatal corticosteroids, Missing, Prednisolone, frequency,32, , , , , , , 
27,Antenatal corticosteroids, Missing, Methyl-prednisolone, frequency,1, , , , , , , 
28,Antenatal corticosteroids, Missing, Inhaled budesonide, frequency,46, , , , , , , 
29,Antenatal corticosteroids, Missing, Early hydrocortisone, frequency, –, , , , , , , 
30,GA at birth (weeks)Median (IQR), No postnatal steroids given for BPD  born &lt;32 weeks GA, 29(27.2–31.4), , , , , , , , , 
31,GA at birth (weeks)Median (IQR), Postnatal steroidsfor BPD  born &lt;32 weeks GA, 25.4(24.4–27.0), , , , , , , , , 
32,GA at birth (weeks)Median (IQR), No postnatal steroids given for BPD  born &lt;27 weeks GA, 25.3(24.1–26.5), , , , , , , , , 
33,GA at birth (weeks)Median (IQR), Postnatal steroids for BPD  born &lt;27 weeks, 24.9(24.1–25.7), , , , , , , , , 
34,Birth weight (g)Median (IQR), No postnatal steroids given for BPD  born &lt;32 weeks GA, 1230(946–1510), , , g, , , , , , 
35,Birth weight (g)Median (IQR), Postnatal steroidsfor BPD  born &lt;32 weeks GA, 720(620–860), , , g, , , , , , 
36,Birth weight (g)Median (IQR), No postnatal steroids given for BPD  born &lt;27 weeks GA, 760(648–880), , , g, , , , , , 
37,Birth weight (g)Median (IQR), Postnatal steroids for BPD  born &lt;27 weeks, 690(607–795), , , g, , , , , , 
38,Male sexn (%), No postnatal steroids given for BPD  born &lt;32 weeks GA, 31 117(54%), , , , , , , , , 
39,Male sexn (%), Postnatal steroidsfor BPD  born &lt;32 weeks GA, 2786(59%), , , , , , , , , 
40,Male sexn (%), No postnatal steroids given for BPD  born &lt;27 weeks GA, 5301(53%), , , , , , , , , 
41,Male sexn (%), Postnatal steroids for BPD  born &lt;27 weeks, 2030(58%), , , , , , , , , 
42,Intubation at birthn (%), No postnatal steroids given for BPD  born &lt;32 weeks GA, 27 509(48%), , , , , , , , , 
43,Intubation at birthn (%), Postnatal steroidsfor BPD  born &lt;32 weeks GA, 4100(87%), , , , , , , , , 
44,Intubation at birthn (%), No postnatal steroids given for BPD  born &lt;27 weeks GA, 9202(92.3%), , , , , , , , , 
45,Intubation at birthn (%), Postnatal steroids for BPD  born &lt;27 weeks, 3278(93%), , , , , , , , , 
46,Antenatal corticosteroidsNone, No postnatal steroids given for BPD  born &lt;32 weeks GA, 3256(6%), , , , , , , , , 
47,Antenatal corticosteroidsNone, Postnatal steroidsfor BPD  born &lt;32 weeks GA, 220(5%), , , , , , , , , 
48,Antenatal corticosteroidsNone, No postnatal steroids given for BPD  born &lt;27 weeks GA, 764(8%), , , , , , , , , 
49,Antenatal corticosteroidsNone, Postnatal steroids for BPD  born &lt;27 weeks, 170(1%), , , , , , , , , 
50,Antenatal corticosteroidsComplete, No postnatal steroids given for BPD  born &lt;32 weeks GA, 39 997(70%), , , , , , , , , 
51,Antenatal corticosteroidsComplete, Postnatal steroidsfor BPD  born &lt;32 weeks GA, 3343(71%), , , , , , , , , 
52,Antenatal corticosteroidsComplete, No postnatal steroids given for BPD  born &lt;27 weeks GA, 6754(68%), , , , , , , , , 
53,Antenatal corticosteroidsComplete, Postnatal steroids for BPD  born &lt;27 weeks, 2434(69%), , , , , , , , , 
54,Antenatal corticosteroidsIncomplete, No postnatal steroids given for BPD  born &lt;32 weeks GA, 10 574(18%), , , , , , , , , 
55,Antenatal corticosteroidsIncomplete, Postnatal steroidsfor BPD  born &lt;32 weeks GA, 807(17%), , , , , , , , , 
56,Antenatal corticosteroidsIncomplete, No postnatal steroids given for BPD  born &lt;27 weeks GA, 2235(22%), , , , , , , , , 
57,Antenatal corticosteroidsIncomplete, Postnatal steroids for BPD  born &lt;27 weeks, 659(17%), , , , , , , , , 
58,Antenatal corticosteroidsMissing, No postnatal steroids given for BPD  born &lt;32 weeks GA, 3479(6%), , , , , , , , , 
59,Antenatal corticosteroidsMissing, Postnatal steroidsfor BPD  born &lt;32 weeks GA, 343(7%), , , , , , , , , 
60,Antenatal corticosteroidsMissing, No postnatal steroids given for BPD  born &lt;27 weeks GA, 249(2%), , , , , , , , , 
61,Antenatal corticosteroidsMissing, Postnatal steroids for BPD  born &lt;27 weeks, 262(7%), , , , , , , , , 
62,Apgar 5 mins≤ 5, No postnatal steroids given for BPD  born &lt;32 weeks GA, 8300(14%), , , , , , , , , 
63,Apgar 5 mins≤ 5, Postnatal steroidsfor BPD  born &lt;32 weeks GA, 1138(24%), , , , , , , , , 
64,Apgar 5 mins≤ 5, No postnatal steroids given for BPD  born &lt;27 weeks GA, 2699(27%), , , , , , , , , 
65,Apgar 5 mins≤ 5, Postnatal steroids for BPD  born &lt;27 weeks, 919(26%), , , , , , , , , 
66,Apgar 5 mins&gt;5, No postnatal steroids given for BPD  born &lt;32 weeks GA, 41 445(72%), , , , , , , , , 
67,Apgar 5 mins&gt;5, Postnatal steroidsfor BPD  born &lt;32 weeks GA, 2880(61%), , , , , , , , , 
68,Apgar 5 mins&gt;5, No postnatal steroids given for BPD  born &lt;27 weeks GA, 6420(64%), , , , , , , , , 
69,Apgar 5 mins&gt;5, Postnatal steroids for BPD  born &lt;27 weeks, 2091(59%), , , , , , , , , 
70,Apgar 5 minsMissing, No postnatal steroids given for BPD  born &lt;32 weeks GA, 7561(13%), , , , , , , , , 
71,Apgar 5 minsMissing, Postnatal steroidsfor BPD  born &lt;32 weeks GA, 695(15%), , , , , , , , , 
72,Apgar 5 minsMissing, No postnatal steroids given for BPD  born &lt;27 weeks GA, 900(9%), , , , , , , , , 
73,Apgar 5 minsMissing, Postnatal steroids for BPD  born &lt;27 weeks, 515(15%), , , , , , , , , 
74,Cardiac massage at deliveryn (%), No postnatal steroids given for BPD  born &lt;32 weeks GA, 2441(4%), , , , , , , , , 
75,Cardiac massage at deliveryn (%), Postnatal steroidsfor BPD  born &lt;32 weeks GA, 315(7%), , , , , , , , , 
76,Cardiac massage at deliveryn (%), No postnatal steroids given for BPD  born &lt;27 weeks GA, 844(8%), , , , , , , , , 
77,Cardiac massage at deliveryn (%), Postnatal steroids for BPD  born &lt;27 weeks, 232(2%), , , , , , , , , 
78,Total length of stay (days)Median (IQR), No postnatal steroids given for BPD  born &lt;32 weeks GA, 47(33–70), , , days, , , , , , 
79,Total length of stay (days)Median (IQR), Postnatal steroidsfor BPD  born &lt;32 weeks GA, 113−92 to 137, , , days, , , , , , 
80,Total length of stay (days)Median (IQR), No postnatal steroids given for BPD  born &lt;27 weeks GA, 88−60 to108, , , days, , , , , , 
81,Total length of stay (days)Median (IQR), Postnatal steroids for BPD  born &lt;27 weeks, 118−99 to 141, , , days, , , , , , 
82,Total days mechanical ventilation (days)Median (IQR), No postnatal steroids given for BPD  born &lt;32 weeks GA, 2(0–5), , , days, , , , , , 
83,Total days mechanical ventilation (days)Median (IQR), Postnatal steroidsfor BPD  born &lt;32 weeks GA, 33(20–48), , , days, , , , , , 
84,Total days mechanical ventilation (days)Median (IQR), No postnatal steroids given for BPD  born &lt;27 weeks GA, 17(4–24), , , days, , , , , , 
85,Total days mechanical ventilation (days)Median (IQR), Postnatal steroids for BPD  born &lt;27 weeks, 37(25–51), , , days, , , , , , 
86,Days to extubation after PNC administered Median (IQR), No postnatal steroids given for BPD  born &lt;32 weeks GA, NA, , , , , , , , , 
87,Days to extubation after PNC administered Median (IQR), Postnatal steroidsfor BPD  born &lt;32 weeks GA, *5(2–13), , , , , , , , , 
88,Days to extubation after PNC administered Median (IQR), No postnatal steroids given for BPD  born &lt;27 weeks GA, NA, , , , , , , , , 
89,Days to extubation after PNC administered Median (IQR), Postnatal steroids for BPD  born &lt;27 weeks, †5(2–12), , , , , , , , , 
90,Extubation1.Extubated and survived, Postnatal steroidsfor BPD  born &lt;32 weeks GA, 1.2768(59%), , , , , , , , , 
91,Extubation1.Extubated and survived, Postnatal steroids for BPD  born &lt;27 weeks, 1.2160(61%), , , , , , , , , 
92,Extubation2.Extubated and died, Postnatal steroidsfor BPD  born &lt;32 weeks GA, 2.546(12%), , , , , , , , , 
93,Extubation2.Extubated and died, Postnatal steroids for BPD  born &lt;27 weeks, 2.420(12%), , , , , , , , , 
94,Extubation3.Not extubated after intubation*, Postnatal steroidsfor BPD  born &lt;32 weeks GA, 3.1333(28%), , , , , , , , , 
95,Extubation3.Not extubated after intubation*, Postnatal steroids for BPD  born &lt;27 weeks, 3.927(26%), , , , , , , , , 
96,Extubation4.Not intubated, Postnatal steroidsfor BPD  born &lt;32 weeks GA, 4. 66(1%), , , , , , , , , 
97,Extubation4.Not intubated, Postnatal steroids for BPD  born &lt;27 weeks, 4.18(1%), , , , , , , , , 
98,Survival to dischargen (%), No postnatal steroids given for BPD  born &lt;32 weeks GA, 52 498(91.6%), , , , , , , , , 
99,Survival to dischargen (%), Postnatal steroidsfor BPD  born &lt;32 weeks GA, 4098(87.0%), , , , , , , , , 
100,Survival to dischargen (%), No postnatal steroids given for BPD  born &lt;27 weeks GA, 6981(69.8%), , , , , , , , , 
101,Survival to dischargen (%), Postnatal steroids for BPD  born &lt;27 weeks, 3052(86.6%), , , , , , , , , 
102,BPD statusn (%), No postnatal steroids given for BPD  born &lt;32 weeks GA, 15 473(27%), , , , , , , , , 
103,BPD statusn (%), Postnatal steroidsfor BPD  born &lt;32 weeks GA, 4289(91.0%), , , , , , , , , 
104,BPD statusn (%), No postnatal steroids given for BPD  born &lt;27 weeks GA, 7101(71.0%), , , , , , , , , 
105,BPD statusn (%), Postnatal steroids for BPD  born &lt;27 weeks, 3285(93.2%), , , , , , , , , 
106,Treated Retinopathy of prematurityn (%), No postnatal steroids given for BPD  born &lt;32 weeks GA, 1247(2.2%), , , , , , , , , 
107,Treated Retinopathy of prematurityn (%), Postnatal steroidsfor BPD  born &lt;32 weeks GA, 1302(27.6%), , , , , , , , , 
108,Treated Retinopathy of prematurityn (%), No postnatal steroids given for BPD  born &lt;27 weeks GA, 880(8.8%), , , , , , , , , 
109,Treated Retinopathy of prematurityn (%), Postnatal steroids for BPD  born &lt;27 weeks, 1166(33.0%), , , , , , , , , 
110,Severe NECn (%), No postnatal steroids given for BPD  born &lt;32 weeks GA, 1143(2.0%), , , , , , , , , 
111,Severe NECn (%), Postnatal steroidsfor BPD  born &lt;32 weeks GA, 693(14.7%), , , , , , , , , 
112,Severe NECn (%), No postnatal steroids given for BPD  born &lt;27 weeks GA, 643(6.4%), , , , , , , , , 
113,Severe NECn (%), Postnatal steroids for BPD  born &lt;27 weeks, 296(8.4%), , , , , , , , , 
114,GI perforationn (%), No postnatal steroids given for BPD  born &lt;32 weeks GA, 877(1.5%), , , , , , , , , 
115,GI perforationn (%), Postnatal steroidsfor BPD  born &lt;32 weeks GA, 290(6.2%), , , , , , , , , 
116,GI perforationn (%), No postnatal steroids given for BPD  born &lt;27 weeks GA, 536(5.4%), , , , , , , , , 
117,GI perforationn (%), Postnatal steroids for BPD  born &lt;27 weeks, 253(7.2%), , , , , , , , , 
118,Brain injury on imagingn (%), No postnatal steroids given for BPD  born &lt;32 weeks GA, 2212(3.9%), , , , , , , , , 
119,Brain injury on imagingn (%), Postnatal steroidsfor BPD  born &lt;32 weeks GA, 443(9.4%), , , , , , , , , 
120,Brain injury on imagingn (%), No postnatal steroids given for BPD  born &lt;27 weeks GA, 1105(11.1%), , , , , , , , , 
121,Brain injury on imagingn (%), Postnatal steroids for BPD  born &lt;27 weeks, 377(10.7%), , , , , , , , , 
